|
gptkbp:instanceOf
|
pediatric oncology staging system
|
|
gptkbp:basisOfStaging
|
pre-treatment clinical and radiological criteria
|
|
gptkbp:citation
|
gptkb:Cohn_SL_et_al.,_Journal_of_Clinical_Oncology,_2009
|
|
gptkbp:criteria
|
age
histology
tumor stage
MYCN status
chromosome 11q status
ploidy
|
|
gptkbp:developedBy
|
gptkb:International_Neuroblastoma_Risk_Group_Task_Force
|
|
gptkbp:fullName
|
gptkb:International_Neuroblastoma_Risk_Group_Staging_System
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
INRG system
|
|
gptkbp:introducedIn
|
2009
|
|
gptkbp:L1Definition
|
localized tumor not involving vital structures as defined by the absence of image-defined risk factors
|
|
gptkbp:L2Definition
|
locoregional tumor with presence of one or more image-defined risk factors
|
|
gptkbp:MDefinition
|
distant metastatic disease (except stage MS)
|
|
gptkbp:MSDefinition
|
metastatic disease in children younger than 18 months with metastases confined to skin, liver, and/or bone marrow
|
|
gptkbp:numberOfStages
|
gptkb:MS
gptkb:L1
gptkb:L2
M
|
|
gptkbp:practicedWorldwide
|
true
|
|
gptkbp:replacedBy
|
gptkb:INSS_system
|
|
gptkbp:riskStratification
|
low risk
high risk
intermediate risk
|
|
gptkbp:usedFor
|
gptkb:neuroblastoma
|
|
gptkbp:bfsParent
|
gptkb:neuroblastoma
|
|
gptkbp:bfsLayer
|
6
|